Cash flow Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 03:59:59 2025-01-29 pm EST			5-day change	1st Jan Change
0.0500 ^CAD	+42.86%		-.--%	+25.00%

Mar. 20	Numinus Wellness Inc. Announces Its Psychedelic-Assisted Therapy Training Program Has Been Officially Approved by the State of Colorado	CI
Mar. 20	Numinus Wellness Brief: Says Approved as a State-Certified Natural Medicine Training Program in Colorado	MT

5b86b9e8fd80593e2f9ab528f.OEAL39pvaCJnjPZGV13UvmIoZ7xDhrUM63YiR6Bq0aQ.TiRaqrhZGXEdvK4ebyyzizB5FPka6sNVggF2HeQ_kOoLd3ydiAINeDjGlQ

Published financial data: NUMINUS WELLNESS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: August	2019	2020	2021	2022	2023
Revenues	107K	881K	1.51M	6.49M	23.18M
Total Revenues	107K	881K	1.51M	6.49M	23.18M
Cost of Goods Sold, Total	664K	798K	1.6M	4.72M	14.81M
Gross Profit	-556K	82.96K	-81.54K	1.78M	8.37M
Selling General & Admin Expenses, Total	3.51M	5.04M	12.09M	23.91M	29.53M
Provision for Bad Debts	-	-	-	-	565K
Stock-Based Compensation (IS)	1.95M	1.88M	1.82M	3.45M	1.87M
R&D Expenses	148K	18.35K	1.4M	1.89M	1.17M
Depreciation & Amortization - (IS)	539K	432K	445K	982K	1.64M
Other Operating Expenses, Total	6.15M	7.37M	15.76M	30.23M	34.77M
Operating Income	-6.7M	-7.28M	-15.84M	-28.45M	-26.4M
Interest Expense, Total	-51.47K	-144K	-114K	-558K	-760K
Interest And Investment Income	-	8.73K	-	129	9.34K
Net Interest Expenses	-51.47K	-135K	-114K	-558K	-750K
Currency Exchange Gains (Loss)	-	-	-	212K	-73.58K
Other Non Operating Income (Expenses)	-	19.74K	-35.72K	13.93K	-535K
EBT, Excl. Unusual Items	-6.75M	-7.4M	-15.99M	-28.78M	-27.75M
Restructuring Charges	-	-	-	-	-564K
Merger & Related Restructuring Charges	-	-	-266K	-2.52M	-
Impairment of Goodwill	-	-	-1.58M	-13.23M	-2.28M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	40.36K	1.26K	-	-
Asset Writedown	-80.64K	-	-897K	-368K	-268K
Other Unusual Items	-500K	-2.25M	-40K	-17.54K	612K
EBT, Incl. Unusual Items	-7.34M	-9.61M	-18.77M	-44.92M	-30.26M
Income Tax Expense	-66.41K	-7.88K	-	-34K	-
Earnings From Continuing Operations	-7.27M	-9.6M	-18.77M	-44.88M	-30.26M
Net Income to Company	-7.27M	-9.6M	-18.77M	-44.88M	-30.26M
Net Income - (IS)	-7.27M	-9.6M	-18.77M	-44.88M	-30.26M
Net Income to Common Incl Extra Items	-7.27M	-9.6M	-18.77M	-44.88M	-30.26M
Net Income to Common Excl. Extra Items	-7.27M	-9.6M	-18.77M	-44.88M	-30.26M
Per Share Items
Net EPS - Basic	-0.1	-0.15	-0.11	-0.18	-0.11
Basic EPS - Continuing Operations	-0.1	-0.15	-0.11	-0.18	-0.11
Basic Weighted Average Shares Outstanding	72.09M	63.81M	165M	256M	264M
Net EPS - Diluted	-0.1	-0.15	-0.11	-0.18	-0.11
Diluted EPS - Continuing Operations	-0.1	-0.15	-0.11	-0.18	-0.11
Diluted Weighted Average Shares Outstanding	72.09M	63.81M	165M	256M	264M
Normalized Basic EPS	-0.06	-0.07	-0.06	-0.07	-0.07
Normalized Diluted EPS	-0.06	-0.07	-0.06	-0.07	-0.07
Supplemental Items
EBITDA	-6.16M	-6.84M	-15.47M	-27.88M	-25.4M
EBITA	-6.7M	-7.28M	-15.84M	-28.41M	-26.32M
EBIT	-6.7M	-7.28M	-15.84M	-28.45M	-26.4M
EBITDAR	-5.78M	-6.77M	-15.44M	-27.79M	-25.24M
Effective Tax Rate - (Ratio)	0.91	0.08	-	0.08	-
Current Domestic Taxes	-	-7.88K	-	-	-
Total Current Taxes	-	-7.88K	-	-	-
Total Deferred Taxes	-	-	-	-34K	-
Normalized Net Income	-4.22M	-4.62M	-9.99M	-17.99M	-17.35M
Interest on Long-Term Debt	-	144K	114K	558K	760K
Supplemental Operating Expense Items
Selling and Marketing Expenses	190K	906K	2.22M	2.19M	1.99M
General and Administrative Expenses	3.32M	4.13M	9.87M	21.71M	27.54M
Research And Development Expense From Footnotes	148K	188K	1.4M	1.89M	1.17M
Net Rental Expense, Total	382K	71.4K	31.44K	83.14K	163K
Imputed Operating Lease Interest Expense	291K	246K	28.34K	78.48K	132K
Imputed Operating Lease Depreciation	91.2K	-174K	3.1K	4.67K	31.35K
Stock-Based Comp., Other (Total)	2.01M	1.88M	1.82M	3.56M	1.87M
Total Stock-Based Compensation	2.01M	1.88M	1.82M	3.56M	1.87M

Fiscal Period: August	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	89.99K	1.63M	59.29M	33.04M	8.58M
Short Term Investments	-	7.5K	-	-	-
Total Cash And Short Term Investments	89.99K	1.63M	59.29M	33.04M	8.58M
Accounts Receivable, Total	22.37K	214K	46.73K	1.4M	1.77M
Other Receivables	107K	328K	469K	204K	164K
Total Receivables	129K	542K	516K	1.6M	1.94M
Inventory	6.49K	-	3.23K	-	-
Prepaid Expenses	77.28K	410K	1.16M	1.48M	1.19M
Other Current Assets, Total	-	85.14K	-	-	346K
Total Current Assets	303K	2.67M	60.97M	36.12M	12.05M
Gross Property Plant And Equipment	3.8M	4.15M	5.03M	14.72M	15.45M
Accumulated Depreciation	-1.17M	-1.71M	-1.88M	-3.33M	-5.65M
Net Property Plant And Equipment	2.63M	2.44M	3.15M	11.38M	9.8M
Long-term Investments	-	-	-	2.37M	2.08M
Goodwill	-	-	-	2.17M	0
Other Intangibles, Total	-	-	-	343K	0
Other Long-Term Assets, Total	145K	13.9K	24.66K	238K	406K
Total Assets	3.08M	5.12M	64.14M	52.63M	24.33M
Liabilities
Accounts Payable, Total	846K	1.5M	1.3M	2.71M	2.89M
Accrued Expenses, Total	288K	-	-	-	-
Short-term Borrowings	334K	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	63.48K	70.68K
Current Portion of Leases	146K	106K	404K	1.38M	1.49M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	-	-	54.59K	235K	197K
Other Current Liabilities	-	402K	150K	196K	-
Total Current Liabilities	1.61M	2.01M	1.91M	4.58M	4.64M
Long-Term Debt	-	40K	-	213K	164K
Long-Term Leases	99.74K	276K	1.2M	6.2M	5.48M
Other Non Current Liabilities	-	-	200K	425K	-
Total Liabilities	1.71M	2.32M	3.31M	11.42M	10.28M
Common Stock, Total	4.94M	18.94M	88.87M	109M	112M
Retained Earnings	-13.35M	-22.95M	-41.73M	-86.61M	-117M
Comprehensive Income and Other	9.78M	6.82M	13.69M	18.62M	18.65M
Total Common Equity	1.37M	2.8M	60.83M	41.21M	14.05M
Total Equity	1.37M	2.8M	60.83M	41.21M	14.05M
Total Liabilities And Equity	3.08M	5.12M	64.14M	52.63M	24.33M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	53.96M	157M	204M	263M	267M
ECS Total Common Shares Outstanding	53.96M	95.85M	203M	256M	266M
Book Value / Share	0.03	0.03	0.3	0.16	0.05
Tangible Book Value	1.37M	2.8M	60.83M	38.7M	14.05M
Tangible Book Value Per Share	0.03	0.03	0.3	0.15	0.05
Total Debt	580K	422K	1.6M	7.85M	7.2M
Net Debt	490K	-1.21M	-57.69M	-25.19M	-1.38M
Debt Equivalent Oper. Leases	3.06M	571K	251K	665K	1.3M
Account Code - Inventory Valuation	6	6	6	3	3
Machinery, Total	2.11M	1.99M	1.56M	2.48M	2.58M
Full Time Employees	16	-	-	-	-
Assets under Capital Lease - Gross	653K	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-167K	-	-	-	-

Fiscal Period: August	2019	2020	2021	2022	2023
Net Income	-7.27M	-9.6M	-18.77M	-44.88M	-30.26M
Depreciation & Amortization - CF	539K	613K	717K	1.47M	2.76M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	35.98K	75.4K
Depreciation & Amortization, Total	539K	613K	717K	1.51M	2.83M
(Gain) Loss From Sale Of Asset	80.64K	-40.36K	-1.26K	108K	258K
(Gain) Loss on Sale of Investments - (CF)	-	-1.5K	1.6K	-183K	295K
Asset Writedown & Restructuring Costs	-	-	2.48M	13.28M	2.55M
Stock-Based Compensation (CF)	1.95M	1.88M	1.82M	3.56M	1.87M
Provision and Write-off of Bad Debts	-	-	-	-	642K
Other Operating Activities, Total	771K	2.3M	148K	648K	120K
Change In Accounts Receivable	-108K	-173K	-128K	98.14K	-1.32M
Change In Inventories	-267K	1.4K	-3.23K	-	-
Change In Accounts Payable	716K	203K	-666K	46.36K	177K
Change in Unearned Revenues	-	-	54.59K	-49.73K	-37.98K
Change in Other Net Operating Assets	-175K	-539K	-1.23M	-360K	118K
Cash from Operations	-3.76M	-5.36M	-15.58M	-26.23M	-22.76M
Capital Expenditure	-875K	-35.2K	-642K	-1.25M	-375K
Sale of Property, Plant, and Equipment	-	-	299K	-	5.88K
Cash Acquisitions	-	70.7K	-402K	1.37M	-
Investment in Marketable and Equity Securities, Total	-	-	5.9K	-	-
Other Investing Activities, Total	122K	-164K	-	-	-
Cash from Investing	-753K	-129K	-739K	123K	-370K
Short Term Debt Issued, Total	88.05K	213K	-	-	-
Long-Term Debt Issued, Total	-	460K	-	-	-
Total Debt Issued	88.05K	673K	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-187K	-348K	-334K	-684K	-2.37M
Total Debt Repaid	-187K	-348K	-334K	-684K	-2.37M
Issuance of Common Stock	4.64M	6.93M	74.32M	692K	916K
Other Financing Activities, Total	-79.16K	-230K	-	-	-
Cash from Financing	4.46M	7.02M	73.98M	7.34K	-1.46M
Foreign Exchange Rate Adjustments	-	-	-	-150K	123K
Net Change in Cash	-51.99K	1.54M	57.67M	-26.25M	-24.46M
Supplemental Items
Cash Interest Paid	-	62.21K	108K	398K	741K
Levered Free Cash Flow	-1.9M	-2.58M	-9.11M	-14.08M	-13.1M
Unlevered Free Cash Flow	-1.87M	-2.49M	-9.04M	-13.73M	-12.63M
Change In Net Working Capital	-642K	389K	1.03M	-231K	454K
Net Debt Issued / Repaid	-99.35K	325K	-334K	-684K	-2.37M

Fiscal Period: August	2019	2020	2021	2022	2023
Profitability
Return on Assets	-144.19	-110.97	-28.59	-30.45	-42.87
Return on Total Capital	-197.26	-188.34	-30.16	-31.9	-46.92
Return On Equity %	-459.19	-460.92	-59.01	-87.97	-109.5
Return on Common Equity	-459.19	-460.92	-59.01	-87.97	-109.5
Margin Analysis
Gross Profit Margin %	-517.63	9.41	-5.39	27.36	36.11
SG&A Margin	3.26K	571.81	798.84	368.11	127.38
EBITDA Margin %	-5.73K	-776.2	-1.02K	-429.28	-109.58
EBITA Margin %	-6.24K	-826.43	-1.05K	-437.55	-113.54
EBIT Margin %	-6.24K	-826.43	-1.05K	-438.1	-113.87
Income From Continuing Operations Margin %	-6.76K	-1.09K	-1.24K	-691.12	-130.53
Net Income Margin %	-6.76K	-1.09K	-1.24K	-691.12	-130.53
Net Avail. For Common Margin %	-6.76K	-1.09K	-1.24K	-691.12	-130.53
Normalized Net Income Margin	-3.93K	-524.68	-660.28	-277.01	-74.83
Levered Free Cash Flow Margin	-1.77K	-292.29	-601.78	-216.75	-56.52
Unlevered Free Cash Flow Margin	-1.74K	-282.11	-597.07	-211.38	-54.47
Asset Turnover
Asset Turnover	0.04	0.21	0.04	0.11	0.6
Fixed Assets Turnover	0.04	0.35	0.54	0.89	2.19
Receivables Turnover (Average Receivables)	-	6.31	11.62	8.99	14.62
Inventory Turnover (Average Inventory)	26.38	-	-	-	-
Short Term Liquidity
Current Ratio	0.19	1.33	31.88	7.88	2.6
Quick Ratio	0.14	1.08	31.27	7.56	2.27
Operating Cash Flow to Current Liabilities	-2.33	-2.67	-8.14	-5.72	-4.9
Days Sales Outstanding (Average Receivables)	-	58.01	31.42	40.6	24.97
Days Outstanding Inventory (Average Inventory)	13.84	-	-	-	-
Average Days Payable Outstanding	343.73	-	-	-	68.97
Long Term Solvency
Total Debt/Equity	42.43	15.06	2.64	19.05	51.25
Total Debt / Total Capital	29.79	13.09	2.57	16	33.88
LT Debt/Equity	7.3	11.28	1.97	15.55	40.16
Long-Term Debt / Total Capital	5.13	9.8	1.92	13.06	26.55
Total Liabilities / Total Assets	55.63	45.36	5.17	21.69	42.26
EBIT / Interest Expense	-130.22	-50.74	-138.75	-51.01	-34.75
EBITDA / Interest Expense	-119.74	-46.46	-132.47	-48.31	-31.01
(EBITDA - Capex) / Interest Expense	-136.74	-46.71	-138.09	-50.54	-31.51
Total Debt / EBITDA	-0.09	-0.06	-0.11	-0.29	-0.31
Net Debt / EBITDA	-0.08	0.18	3.81	0.94	0.06
Total Debt / (EBITDA - Capex)	-0.08	-0.06	-0.1	-0.28	-0.3
Net Debt / (EBITDA - Capex)	-0.07	0.18	3.66	0.89	0.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-96.18	719.87	71.78	329.03	256.95
Gross Profit, 1 Yr. Growth %	-206.27	-114.91	-198.29	-2.28K	371.16
EBITDA, 1 Yr. Growth %	156.53	10.97	126.24	80.15	-8.88
EBITA, 1 Yr. Growth %	151.4	8.64	117.53	79.37	-7.37
EBIT, 1 Yr. Growth %	151.4	8.64	117.53	79.6	-7.22
Earnings From Cont. Operations, 1 Yr. Growth %	161.98	32.08	95.55	139.06	-32.59
Net Income, 1 Yr. Growth %	161.98	32.08	95.55	139.06	-32.59
Normalized Net Income, 1 Yr. Growth %	153.33	9.52	116.17	80.12	-3.57
Diluted EPS Before Extra, 1 Yr. Growth %	147.05	49.21	-24.35	53.89	-44.62
Accounts Receivable, 1 Yr. Growth %	-	226.68	-78.15	2.89K	26.85
Inventory, 1 Yr. Growth %	-85.19	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	10.92	-7.37	29.21	261.44	-13.96
Total Assets, 1 Yr. Growth %	12.74	66.37	1.15K	-17.95	-53.77
Tangible Book Value, 1 Yr. Growth %	-24.08	104.9	2.07K	-36.38	-63.7
Common Equity, 1 Yr. Growth %	-24.08	104.9	2.07K	-32.25	-65.91
Cash From Operations, 1 Yr. Growth %	180	42.41	190.89	68.37	-13.23
Capital Expenditures, 1 Yr. Growth %	-50.34	-95.98	1.72K	94.15	-69.88
Levered Free Cash Flow, 1 Yr. Growth %	-	64	253.67	54.53	-6.92
Unlevered Free Cash Flow, 1 Yr. Growth %	-	61.6	263.56	51.89	-8.01
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-44.02	275.28	171.47	291.33
Gross Profit, 2 Yr. CAGR %	-	-60.19	-61.72	362.79	913.26
EBITDA, 2 Yr. CAGR %	-	68.72	58.45	101.89	28.12
EBITA, 2 Yr. CAGR %	-	65.26	53.73	97.53	28.9
EBIT, 2 Yr. CAGR %	-	65.26	53.73	97.66	29.08
Earnings From Cont. Operations, 2 Yr. CAGR %	-	86.02	60.71	116.22	26.95
Net Income, 2 Yr. CAGR %	-	86.02	60.71	116.22	26.95
Normalized Net Income, 2 Yr. CAGR %	-	66.56	53.86	97.25	31.79
Diluted EPS Before Extra, 2 Yr. CAGR %	-	91.99	6.25	7.9	0.41
Accounts Receivable, 2 Yr. CAGR %	-	-	-15.51	155.68	516
Inventory, 2 Yr. CAGR %	-	-	-29.45	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	1.36	9.4	116.11	76.34
Total Assets, 2 Yr. CAGR %	-	36.96	356.39	220.5	-38.41
Tangible Book Value, 2 Yr. CAGR %	-	24.72	567.25	271.8	-51.94
Common Equity, 2 Yr. CAGR %	-	24.72	567.25	283.69	-51.94
Cash From Operations, 2 Yr. CAGR %	-	99.69	103.53	121.31	20.87
Capital Expenditures, 2 Yr. CAGR %	-	-85.86	-14.33	495.04	-23.52
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	140.84	133.78	19.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	142.39	134.99	18.2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-18.65	292.4	197.41
Gross Profit, 3 Yr. CAGR %	-	-	-46.2	47.26	365.56
EBITDA, 3 Yr. CAGR %	-	-	86.05	65.38	54.86
EBITA, 3 Yr. CAGR %	-	-	81.12	61.84	53.46
EBIT, 3 Yr. CAGR %	-	-	81.12	61.91	53.61
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	89.14	83.46	46.61
Net Income, 3 Yr. CAGR %	-	-	89.14	83.46	46.61
Normalized Net Income, 3 Yr. CAGR %	-	-	81.69	62.12	55.39
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	40.76	20.21	-8.63
Accounts Receivable, 3 Yr. CAGR %	-	-	-	177.44	102.41
Inventory, 3 Yr. CAGR %	-	-	-58.07	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	9.91	62.94	58.98
Total Assets, 3 Yr. CAGR %	-	-	186.36	157.58	68.09
Tangible Book Value, 3 Yr. CAGR %	-	-	223.33	204.83	71.21
Common Equity, 3 Yr. CAGR %	-	-	223.33	211.29	71.21
Cash From Operations, 3 Yr. CAGR %	-	-	126.36	91.06	61.98
Capital Expenditures, 3 Yr. CAGR %	-	-	-28.57	12.53	120.12
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	107.72	71.98
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	107.42	71.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	52.48
Gross Profit, 5 Yr. CAGR %	-	-	-	-	74.09
EBITDA, 5 Yr. CAGR %	-	-	-	-	60.26
EBITA, 5 Yr. CAGR %	-	-	-	-	58.08
EBIT, 5 Yr. CAGR %	-	-	-	-	58.17
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	61.26
Net Income, 5 Yr. CAGR %	-	-	-	-	61.26
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	59.77
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	22.97
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	32.79
Total Assets, 5 Yr. CAGR %	-	-	-	-	54.87
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	50.83
Common Equity, 5 Yr. CAGR %	-	-	-	-	50.83
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	76.12
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-26.59